Back
BlueLinx Holdings 10K Form
Buy
53
BXC
BlueLinx Holdings
Last Price:
123.34
Seasonality Move:
10.59%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-30 | 10Q | BXC/BlueLinx Holdings Quarterly |
2024-02-20 | 10K | BXC/BlueLinx Holdings Annual |
2023-10-31 | 10Q | BXC/BlueLinx Holdings Quarterly |
2023-08-01 | 10Q | BXC/BlueLinx Holdings Quarterly |
2023-05-02 | 10Q | BXC/BlueLinx Holdings Quarterly |
2023-02-21 | 10K | BXC/BlueLinx Holdings Annual |
Receive BXC News And Ratings
See the #1 stock for the next 7 days that we like better than BXC
BXC Financial Statistics
Sales & Book Value
Annual Sales: | $3.14B |
---|---|
Cash Flow: | $53.84M |
Price / Cash Flow: | 8.94 |
Annual Sales: | $77.83 |
Price / Book: | 1.49 |
Profitability
EPS (TTM): | 3.53000 |
---|---|
Net Income (TTM): | $29.72M |
Gross Margin: | $527.02M |
Return on Equity: | 4.61% |
Return on Assets: | 1.88% |
BlueLinx Holdings Earnings Forecast
Key BlueLinx Holdings Financial Ratios
- The Gross Profit Margin over the past 24 years for BXC is 16.80%.
- The Selling, General & Administrative Expenses for BXC have been equal to 11.34% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 48.92% of Operating Income.
- The Net Earning history of BXC is 1.55% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 14 years.
BlueLinx Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Trading Companies & Distributors |
Sector: | Industrials |
Current Symbol: | BXC |
CUSIP: | 09624H |
Website: | bluelinxco.com |
Debt
Debt-to-Equity Ratio: | 0.45 |
---|---|
Current Ratio: | 4.58 |
Quick Ratio: | 3.12 |
Price-to-Earnings
Trailing P/E Ratio: | 21.61 |
---|---|
Forward P/E Ratio: | 18.48 |
BXC Technical Analysis vs Fundamental Analysis
Buy
53
BlueLinx Holdings (BXC)
is a Buy
Is BlueLinx Holdings a Buy or a Sell?
-
BlueLinx Holdings stock is rated a Buy
The current BlueLinx Holdings [BXC] share price is $116.48. The Score for BXC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.